Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypican-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinoma. [electronic resource]
- Hepatology research : the official journal of the Japan Society of Hepatology May 2010
- 477-85 p. digital